The American College of Surgeons (ACS) and the Commission on Cancer (CoC) advocate for concurrent abstracting and more timely submissions, but cancer programs, specifically registry teams, struggle to find innovative ways to meet this demand.
Dauphne McGavic, RN, MSN, CTR, Director of Oncology Accreditation & Support Svcs, Ascension St. Thomas, and her team worked with OncoLens to test integration with the CRStar Cancer Registry solution. The solution leverages OncoLens tumor board data to accelerate reportability and case finding, and support the registry’s broader data and abstraction concurrency objectives.
Findings point to a reduction in case finding time by an average of 40 percent and a “Ready to Abstract” percentage of more than 80 percent.
Complete our short form to download a complete copy of “Time‑Saving Opportunities through Tumor Board and Cancer Registry Integration.”
Latest
